Proxy Votes Now

Home › Funds › Baron Health Care Fund

Baron Health Care Fund (BHCFX) proxy voting record 2025-2026

Fund family: BARON SELECT FUNDS · Filed by BARON SELECT FUNDS (CIK 1217673) · SEC series S000061847

Share classes and tickers: BHCFX (C000200239), BHCHX (C000200240), BHCUX (C000200241)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 447 with, 14 against, 0 abstentions (not counted as with management). Shareholder proposals: 2 FOR, 12 AGAINST, 0 abstained, by the filing’s own vote-source field.

Where this fund voted differently from most BARON SELECT FUNDS funds

Each ballot item this fund voted is set against the votes of the other BARON SELECT FUNDS funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most BARON SELECT FUNDS funds on 3 items (30.0% of the 10 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost BARON SELECT FUNDS fundsMgmtResult
Eli Lilly and Company2026-05-04Shareholder Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair.AgainstFOR — 3 of 3 BARON SELECT FUNDS fundsForNot approved, 33.7% support
Eli Lilly and Company2026-05-04Shareholder Shareholder proposal to prepare an annual lobbying report.AgainstFOR — 3 of 3 BARON SELECT FUNDS fundsForNot approved, 14.9% support
Eli Lilly and Company2026-05-04Election of the following directors, each to serve a three-year term: William Kaelin, Jr.ForAGAINST — 3 of 3 BARON SELECT FUNDS fundsForElected, 95.1% support

Download all 3 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 81.1% of this fund’s 461 such votes could be given a sector; the other 87 (18.9%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Health Care321144.4%
Industrials3800.0%
Real Estate1100.0%
Technology400.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections2820
Audit-related470
Say-on-Pay440
Compensation290
Capital Structure270
Corporate Governance278
Other Social Issues43
Environment or Climate33
Shareholder Rights and Defenses20

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Eli Lilly and CompanyMay 4, 2026$19M102
argenx SENovember 18, 2025$12M10
Thermo Fisher Scientific Inc.May 20, 2026$7M130
McKesson CorporationJuly 30, 2025$7M140
Mettler-Toledo International Inc.May 7, 2026$7M110
Johnson & JohnsonApril 23, 2026$6M151
Teva Pharmaceutical Industries LimitedMay 28, 2026$6M30
argenx SEMay 6, 2026$5M120

Notable votes against management

MeetingCompanyProposalFundMgmt
May 4, 2026Eli Lilly and CompanyShareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposalAgainstFor
May 4, 2026Eli Lilly and CompanyShareholder proposal to prepare an annual lobbying report. Shareholder proposalAgainstFor
April 23, 2026Johnson & JohnsonIndependent Board Chair Shareholder proposalAgainstFor
May 8, 2026AbbVie Inc.Stockholder Proposal - to Adopt a Policy to Require an Independent Chair Shareholder proposalAgainstFor
April 30, 2026Gilead Sciences, Inc.To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting. Shareholder proposalAgainstFor
April 30, 2026Gilead Sciences, Inc.To vote on a stockholder proposal requesting a report on the impact of extended patent exclusivities on patient access, if properly presented at the Annual Meeting. Shareholder proposalAgainstFor
May 12, 2026IDEXX Laboratories, Inc.Shareholder Proposal to Give Shareholders the Ability to Call for a Special Shareholder Meeting (Proposal Six). Shareholder proposalAgainstFor
May 13, 2026Vertex Pharmaceuticals IncorporatedShareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written consent. Shareholder proposalForAgainst
May 26, 2026Merck & Co., Inc.Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposalAgainstFor
May 26, 2026Merck & Co., Inc.Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposalAgainstFor
May 4, 2026West Pharmaceutical Services, Inc.Shareholder proposal regarding an independent Board Chair policy. Shareholder proposalAgainstFor
April 30, 2026Boston Scientific CorporationStockholder proposal titled "Give Shareholders the Ability to Call for a Special Shareholder Meeting." Shareholder proposalForAgainst

Search this fund’s votes by company

465 ballot items at 47 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Baron Health Care Fund (BHCFX) voted at 47 shareholder meetings of 46 companies, on 465 ballot items in all. Where management made a recommendation, the fund followed it on 97.0% of the items and voted against it 14 times. Its most frequent area of disagreement was corporate governance (8 of its votes against management). It voted on 14 shareholder proposals. It voted differently from most BARON SELECT FUNDS funds on 3 items.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.